NeoGenomics: Mark Mallon

NeoGenomics has announced that Mark Mallon is stepping down as CEO and a member of the board of directors, effective immediately. The decision was not the result of any disagreements about strategy with management or the board, inappropriate action by the CEO, or any violation of company policy or any accounting irregularity, the company said in a statement. 

Lynn Tetrault, the current chair of the board, has been appointed executive chairman and an interim office of the CEO has been established that includes CFO William Bonello, Chief Strategy and Corporate Development Officer Douglas Brown, and Chief Culture Officer Jennifer Balliet. Each executive will retain their current positions while carrying out new responsiblities, the company added.